Literature DB >> 18560019

pVHL: a multipurpose adaptor protein.

Ian J Frew1, Wilhelm Krek.   

Abstract

Mutations in the von Hippel-Lindau tumor suppressor gene VHL occur in various inherited and sporadically occurring tumors. The protein encoded by VHL--pVHL--bears no known enzymatic activities but interacts with numerous protein partners. With the identification of distinct pVHL-containing multiprotein complexes, a refined portrait of pVHL tumor suppressor function has arisen. In general, pVHL acts as a multipurpose adaptor protein that controls a diverse array of gene expression programs, as well as extracellular matrix assembly and microtubule-based processes, by linking various target proteins to appropriate enzymatic activities. These findings provide an evermore complex but coherent view of how pVHL functions molecularly and of the consequences of dysregulation of these diverse molecular activities on tumor formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560019     DOI: 10.1126/scisignal.124pe30

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  40 in total

1.  HIF1α and pancreatic β-cell development.

Authors:  Mylène Heinis; Andrea Soggia; Camille Bechetoille; Marie-Thérèse Simon; Carole Peyssonnaux; Pierre Rustin; Raphael Scharfmann; Bertrand Duvillié
Journal:  FASEB J       Date:  2012-03-16       Impact factor: 5.191

2.  Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?

Authors:  Adriana von Teichman; Martina Storz; Susanne Dettwiler; Holger Moch; Peter Schraml
Journal:  Virchows Arch       Date:  2012-09-25       Impact factor: 4.064

3.  von Hippel-Lindau gene disruption in mouse pancreatic progenitors and its consequences on endocrine differentiation in vivo: importance of HIF1-α and VEGF-A upregulation.

Authors:  Andrea Soggia; Cyrille Ramond; Haruhiko Akiyama; Raphaël Scharfmann; Bertrand Duvillie
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

4.  Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy.

Authors:  Javid Moslehi; Yoji Andrew Minamishima; Jianru Shi; Donna Neuberg; David M Charytan; Robert F Padera; Sabina Signoretti; Ronglih Liao; William G Kaelin
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

5.  Actin Cytoskeletal Organization in Drosophila Germline Ring Canals Depends on Kelch Function in a Cullin-RING E3 Ligase.

Authors:  Andrew M Hudson; Katelynn M Mannix; Lynn Cooley
Journal:  Genetics       Date:  2015-09-16       Impact factor: 4.562

6.  The von Hippel-Lindau protein pVHL inhibits ribosome biogenesis and protein synthesis.

Authors:  Wen-Ting Zhao; Cheng-Fu Zhou; Xue-Bing Li; Yun-Fang Zhang; Li Fan; Jerry Pelletier; Jing Fang
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.

Authors:  Qiliang Cai; Suhbash C Verma; Pankaj Kumar; Michelle Ma; Erle S Robertson
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  The VHL-dependent regulation of microRNAs in renal cancer.

Authors:  Calida S Neal; Michael Z Michael; Lesley H Rawlings; Mark B Van der Hoek; Jonathan M Gleadle
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

Review 9.  [Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses].

Authors:  G Boysen; B Wollscheid; D Bausch-Fluck; P Schraml; H Moch
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

10.  The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIM(EL).

Authors:  Y Guo; M C Schoell; R S Freeman
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.